3) what is a "poster" and "poster presentation" exactly?
4) who attends AARC... just cancer researchers... or pharmaceutical co, buy side and sell side analysts?
5) was anything exciting and meaningful released in the 2018 AARC annual meeting?
thank you in anticipation[/QUOTE
1. Normally the presentation happens after close of trading in Australia, so we should get ASX release before resuming trade the next morning.
2. The panel who revue the submissions would be the only people to see presentation prior, and they would be on signe NDAs.
3. A poster is pinned up out in the foyer. A presentation is on the main stage.
4 attendees are researchers, doctors, pharma, Biotechs , analysts. Any body who makes money out of Cancer. That’s what is so exciting , the money will be in the room watching 2 presentations with data around a brand new approach to treating cancer. And many Will learn for the first time that IMU can hit their patented and valuable checkpoints . So their highly lucrative drugs that have patented checkpoints are under threat from a very low cost side effect free competitor. The asset is not the drug it’s he checkpoint.
5. I don’t know the answer to that question.
I hope that helps. This is incredibly exciting time for IMU. As LC and PH say “it’s the DATA”
Considering the ability to sidestep patents , at a low cost, with no side effects, big pharma and big biotech will sit up and take notice here. As LC said this is vetted by experts before presentation. So they are very impressed . If IMU don’t own the space they are certainly way in front in the race for B CELL immunotherapy.
(20min delay)
